All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Flu vaccine uptake varies by sociodemographic factors in CKD patients
Sep 26, 2023
Just under three-quarters of patients with chronic kidney disease receive flu vaccines
Immune response not inferior with coadministration of COVID-19, flu shots
Sep 14, 2023
A similar immune response and no increase in the rate of reactogenicity events was seen with coadministration versus administering the COVID-19 vaccine alone.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
FDA approves Pfizer RSV vaccine for older adults
Jun 01, 2023
The CDC is expected to meet later in the month to adopt vaccine recommendations for older Americans.
FDA panel backs second RSV vaccine for older Americans
Mar 02, 2023
In a two-part vote, the panel voted 10-to-2 in favor of the vaccine’s safety and unanimously on the shot’s effectiveness.
Moderna will offer free COVID-19 shots to uninsured after PHE ends
Feb 16, 2023
Moderna faces pressure since the US government subsidized its vaccine development.